Prediabetes and Type 2 Diabetes in Aging
Launched by UŞAK UNIVERSITY · Apr 29, 2025
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Type 2 Diabetes Mellitus develops due to insulin resistance and/or decreased insulin secretion and is particularly common in the elderly population. With the aging process, metabolic changes and increased insulin resistance increase the risk of diabetes. Long-term complications of diabetes can negatively affect the quality of life in geriatric individuals with effects such as cognitive impairment, loss of physical function and fatigue. In individuals with diabetes, hyperglycemia, microvascular complications and inflammation can increase the risk of cognitive decline. This can pave the way f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • for people without diabetes (healthy), those with Hemoglobin A1c Levels (HbA1c) normal range between 4% and 5.6%,
- • those with HbA1c level between 5.7% and 6.4%, those with prediabetes (Impaired Glucose Tolerance),
- • those with 6.5% -7.5% level and
- • those with HbA1c level above 7.5
- • criteria are being 60 years of age and older,
- Exclusion Criteria:
- • those who have major depression,
- • uncontrolled thyroid disease,
- • those with vitamin B12, folic acid deficiency and anemia,
- • those with uncontrolled hypertension,
- • those with nephropathy and retrophy,
- • those with any neuropsychological disorder, a history of alcohol, substance or drug addiction,
- • those using any neurological or psychological medication (anticonvulsant drugs, antidepressants, anxiolytics, etc.),
- • those with Alzheimer's and Parkinson's disease,
- • those with cancer,
- • those with lung disease
About Uşak University
Uşak University is a distinguished academic institution dedicated to advancing research and education in various fields, including the health sciences. As a clinical trial sponsor, Uşak University is committed to fostering innovation and contributing to medical knowledge through rigorous scientific investigation. The university collaborates with healthcare professionals and researchers to conduct high-quality clinical trials that aim to improve patient outcomes and enhance therapeutic interventions. With a focus on ethical standards and regulatory compliance, Uşak University strives to ensure the integrity and reliability of its research initiatives, ultimately benefiting the broader community and the advancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Usak, , Turkey
Patients applied
Trial Officials
Kevser Gursan, Dr.
Principal Investigator
Uşak University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported